Pros
Insurance benefits are fully covered.
Cons
Adding prescribing providers rather than retaining the ones they have is the sole focus of the company. Pure Silicon Valley model intended to maximize profits for those at the top on the backs of those that do all the actual work. Major funding provided by a venture capital group, so there is clear influence from non-clinical players shaping the course of decisions made. Goal = add 2 clinicians for every 1 you lose = expansion = $UCCE$$. Perhaps this works when you're selling smart watches. Not so much when clinical care delivery or provider retention and the care continuity that comes with are concerned. As soon as the Dept of Health and Human Services rolls back the emergency mandate allowing controlled substances to be prescribed across state lines along with the Ryan Haight act, the platform will implode.